Literature DB >> 2153049

Identification of an Mr 70,000 antigen associated with Reed-Sternberg cells and interdigitating reticulum cells.

P L Hsu1, S M Hsu.   

Abstract

We obtained a monoclonal antibody that has restricted reactivity with tumor cells [Hodgkin's mononuclear cells and Reed-Sternberg (H-RS) cells] in Hodgkin's disease by immunizing mice with 12-O-tetradecanoyl phorbol-13-acetate-induced H-RS cells. The antibody, anti-IRac, reacted with H-RS cells in 8 of 20 patients who had Hodgkin's disease, as well as with interdigitating reticulum cells in dermatopathic lymph nodes and with cells of three H-RS cell lines, HDLM-1, L428, and KM-H2. The antigen IRac is a protein of molecular weight 70,000 which we found to have the following properties. (a) After 12-O-tetradecanoyl phorbol-13-acetate induction, the expression of IRac was decreased slightly in HDLM and L428 cells but increased in KM-H2. This is in contrast to a rapid decrease in the expression of two other H-RS-cell-associated antigens, CD30 and 2H9, in all 12-O-tetradecanoyl phorbol-13-acetate-treated H-RS cells. Thus, IRac may be associated with H-RS cells at advanced stages of differentiation, and its expression may not be attributable solely to cellular proliferation. (b) IRac was detected rarely in normal or in antigen- or mitogen-activated lymphocytes but was observed frequently in virus-transformed B- or T-lymphocytes. These findings were similar to those with CD30 and 2H9, indicating that the expression of all three of these antigens is probably under a similar regulatory control. (c) IRac was absent from cells in most non-Hodgkin's lymphomas; its expression could not be modulated by treatment of cells with anti-IRac. We conclude that use of IRac could facilitate the diagnosis of Hodgkin's disease and that it may be suitable for immunotherapy or immunoimaging. The expression of IRac in both H-RS cells and interdigitating reticulum cells, along with earlier evidence, indicates that H-RS cells have antigenic and functional similarities to interdigitating reticulum cells or to cells of interdigitating reticulum cell/histiocyte lineage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153049

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.

Authors:  S M Hsu; S S Xie; P L Hsu; J A Waldron
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Correlation of c-fos/c-jun expression with histiocytic differentiation in Hodgkin's Reed-Sternberg cells. Examination in HDLM-1 subclones with spontaneous differentiation.

Authors:  S M Hsu; S S Xie; M O el-Okda; P L Hsu
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

3.  Cultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.

Authors:  S M Hsu; S S Xie; P L Hsu
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?

Authors:  G S Pinkus; J L Pinkus; E Langhoff; F Matsumura; S Yamashiro; G Mosialos; J W Said
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.

Authors:  B D Hock; G C Starling; P B Daniel; D N Hart
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

Review 6.  Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma.

Authors:  Christoph Renner; Frank Stenner
Journal:  Front Oncol       Date:  2018-06-04       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.